These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 39251935)

  • 1. Advanced glycation end products and reactive oxygen species: uncovering the potential role of ferroptosis in diabetic complications.
    Chen Y; Meng Z; Li Y; Liu S; Hu P; Luo E
    Mol Med; 2024 Sep; 30(1):141. PubMed ID: 39251935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives.
    Khalid M; Petroianu G; Adem A
    Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions.
    Neviere R; Yu Y; Wang L; Tessier F; Boulanger E
    Glycoconj J; 2016 Aug; 33(4):607-17. PubMed ID: 27277623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dynamic roles of advanced glycation end products.
    Khalid M; Adem A
    Vitam Horm; 2024; 125():1-29. PubMed ID: 38997161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of advanced glycation end products and insulin resistance in diabetic nephropathy.
    Parwani K; Mandal P
    Arch Physiol Biochem; 2023 Feb; 129(1):95-107. PubMed ID: 32730131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulatory role of HMG-CoA reductase inhibitors and ezetimibe on LDL-AGEs-induced ROS generation and RAGE-associated signalling in HEK-293 Cells.
    Nabi R; Alvi SS; Shah A; Chaturvedi CP; Iqbal D; Ahmad S; Khan MS
    Life Sci; 2019 Oct; 235():116823. PubMed ID: 31476307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced Glycation End Products: Potential Mechanism and Therapeutic Target in Cardiovascular Complications under Diabetes.
    Yang P; Feng J; Peng Q; Liu X; Fan Z
    Oxid Med Cell Longev; 2019; 2019():9570616. PubMed ID: 31885827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assay for advanced glycation end products generating intracellular oxidative stress through binding to its receptor.
    Kobori T; Ganesh D; Kumano-Kuramochi M; Torigoe K; Machida S
    Anal Biochem; 2020 Dec; 611():114018. PubMed ID: 33186591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrahedral Framework Nucleic Acids Based Small Interfering RNA Targeting Receptor for Advanced Glycation End Products for Diabetic Complications Treatment.
    Cai Z; Li Y; Bai L; Xu J; Liu Z; Zhang T; Gao S; Lin Y
    ACS Nano; 2023 Nov; 17(22):22668-22683. PubMed ID: 37751401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological Role of Advanced Glycation End Products (AGEs) and their Receptor Axis in Atrial Fibrillation.
    Yamagishi SI; Sotokawauchi A; Matsui T
    Mini Rev Med Chem; 2019; 19(13):1040-1048. PubMed ID: 30854960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Glycation Angle to Look into the Diabetic Vasculopathy: Cause and Cure.
    Ahmad S; Siddiqui Z; Rehman S; Khan MY; Khan H; Khanum S; Alouffi S; Saeed M
    Curr Vasc Pharmacol; 2017; 15(4):352-364. PubMed ID: 28356033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications.
    Yamagishi S; Fukami K; Matsui T
    Cardiovasc Diabetol; 2015 Jan; 14():2. PubMed ID: 25582643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress.
    Wei Q; Ren X; Jiang Y; Jin H; Liu N; Li J
    BMC Cardiovasc Disord; 2013 Mar; 13():13. PubMed ID: 23497312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation end products (sRAGE) in diabetes.
    Yamagishi S; Matsui T; Nakamura K
    Curr Drug Targets; 2007 Oct; 8(10):1138-43. PubMed ID: 17979674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fructose causes endothelial cell damage via activation of advanced glycation end products-receptor system.
    Sotokawauchi A; Matsui T; Higashimoto Y; Yamagishi SI
    Diab Vasc Dis Res; 2019 Nov; 16(6):556-561. PubMed ID: 31375034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions.
    Sanajou D; Ghorbani Haghjo A; Argani H; Aslani S
    Eur J Pharmacol; 2018 Aug; 833():158-164. PubMed ID: 29883668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pinocembrin Protects from AGE-Induced Cytotoxicity and Inhibits Non-Enzymatic Glycation in Human Insulin.
    Borriello M; Iannuzzi C; Sirangelo I
    Cells; 2019 Apr; 8(5):. PubMed ID: 31035509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteomeles schwerinae extracts inhibits the binding to receptors of advanced glycation end products and TGF-β1 expression in mesangial cells under diabetic conditions.
    Kim YS; Jung DH; Lee IS; Pyun BJ; Kim JS
    Phytomedicine; 2016 Apr; 23(4):388-97. PubMed ID: 27002409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Advanced Glycation End products (AGEs) and its receptor (RAGE) on cancer metabolic signaling pathways and its progression.
    Muthyalaiah YS; Jonnalagadda B; John CM; Arockiasamy S
    Glycoconj J; 2021 Dec; 38(6):717-734. PubMed ID: 35064413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AGE/RAGE in diabetic kidney disease and ageing kidney.
    Wu XQ; Zhang DD; Wang YN; Tan YQ; Yu XY; Zhao YY
    Free Radic Biol Med; 2021 Aug; 171():260-271. PubMed ID: 34019934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.